Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer.

Chan E, Arlinghaus LR, Cardin DB, Goff L, Berlin JD, Parikh A, Abramson RG, Yankeelov TE, Hiebert S, Merchant N, Bhaskara S, Chakravarthy AB
Radiother Oncol. 2016 119 (2): 312-8

PMID: 27106554 · PMCID: PMC4961249 · DOI:10.1016/j.radonc.2016.04.013

MeSH Terms (12)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Capecitabine Chemoradiotherapy Diffusion Magnetic Resonance Imaging Humans Male Maximum Tolerated Dose Middle Aged Pancreatic Neoplasms

Connections (2)

This publication is referenced by other Labnodes entities: